Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults. [electronic resource]
Producer: 20160518Description: 4647-52 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- administration & dosage
- Aged
- Aged, 80 and over
- Antibodies, Bacterial -- blood
- Antibodies, Viral -- blood
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Hemagglutination Inhibition Tests
- Humans
- Immunization Schedule
- Influenza Vaccines -- administration & dosage
- Male
- Opsonin Proteins -- blood
- Pneumococcal Vaccines -- administration & dosage
- Polysorbates -- administration & dosage
- Serum Bactericidal Antibody Assay
- Squalene -- administration & dosage
- Treatment Outcome
- Vaccines, Inactivated -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.